- cafead   Mar 08, 2023 at 09:52: PM
via Biogen (NASDAQ:BIIB) and Sage Therapeutics (NASDAQ:SAGE) said the U.S. Food and Drug Administration (FDA) currently does not plan to hold an advisory committee meeting to discuss an application seeking approval of oral medicine zuranolone to treat major depressive disorder (MDD) and postpartum depression (PPD).
article source
article source